Literature DB >> 21263238

Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component.

Carlo Visco1, Sylvia Hoeller, Jeffrey T Malik, Zijun Y Xu-Monette, Michele L Wiggins, Jessica Liu, Warren G Sanger, Zhongfeng Liu, Julie Chang, Erik A Ranheim, Joel F Gradowski, Sergio Serrano, Huan-You Wang, Qingquan Liu, Sandeep Dave, Brian Olsen, Randy D Gascoyne, Elias Campo, Steven H Swerdlow, Wing C Chan, Alexander Tzankov, Ken H Young.   

Abstract

The normal counterparts of mantle cell lymphoma (MCL) are naive, quiescent B cells that have not been processed through the germinal center (GC). For this reason, although lymphomas arising from GC or post-GC B cells often exhibit plasmacytic differentiation, MCL rarely presents with plasmacytic features. Seven cases of MCL with a monotypic plasma cell (PC) population were collected from 6 centers and were studied by immunohistochemistry, fluorescence immunophenotyping and interphase cytogenetics as a tool for the investigation of neoplasms analysis, capillary gel electrophoresis, and restriction fragment length polymorphism of immunoglobulin heavy chain analysis of microdissections of each of the MCL and PC populations to assess their clonal relationship. The clinical presentation was rather unusual compared with typical MCL, with 2 cases arising from the extranodal soft tissues of the head. All MCL cases were morphologically and immunohistochemically typical, bearing the t(11;14)(q13;q32). In all cases, the PC population was clonal. In 5 of the 7 cases, the MCL and PC clones showed identical restriction fragments, indicating a common clonal origin of the neoplastic population. The 2 cases with clonal diversity denoted the coexistence of 2 different tumors in a composite lymphoma/PC neoplasm. Our findings suggest that MCL can present with a PC component that is often clonally related to the lymphoma, representing a rare but unique biological variant of this tumor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21263238      PMCID: PMC3079277          DOI: 10.1097/PAS.0b013e3182049a9c

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  47 in total

1.  Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program.

Authors:  A L Shaffer; Kuo I Lin; Tracy C Kuo; Xin Yu; Elaine M Hurt; Andreas Rosenwald; Jena M Giltnane; Liming Yang; Hong Zhao; Kathryn Calame; Louis M Staudt
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

2.  Evolution of autoantibody responses via somatic hypermutation outside of germinal centers.

Authors:  Jacqueline William; Chad Euler; Sean Christensen; Mark J Shlomchik
Journal:  Science       Date:  2002-09-20       Impact factor: 47.728

3.  Simultaneous evaluation of T- and B-cell clonality, t(11;14) and t(14;18), in a single reaction by a four-color multiplex polymerase chain reaction assay and automated high-resolution fragment analysis: a method for the rapid molecular diagnosis of lymphoproliferative disorders applicable to fresh frozen and formalin-fixed, paraffin-embedded tissues, blood, and bone marrow aspirates.

Authors:  V S Meier; A Rufle; F Gudat
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

4.  Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.

Authors:  S Zupo; R Massara; M Dono; E Rossi; F Malavasi; M E Cosulich; M Ferrarini
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

Review 5.  CD5+ true SLL/CLL with plasmacytic differentiation and an unusual 1p36 translocation: case report and review of the literature.

Authors:  H L Evans; J M Polski; V Deshpande; C H Dunphy
Journal:  Leuk Lymphoma       Date:  2000-11

6.  Analysis of clonal relationship using single-cell polymerase chain reaction in a patient with concomitant mantle cell lymphoma and multiple myeloma.

Authors:  M Yamaguchi; T Ohno; E Miyata; H Toyoda; K Nishii; M Masuya; K Kita; H Shiku
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

7.  Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses.

Authors:  José Ignacio Martín-Subero; Ilse Chudoba; Lana Harder; Stefan Gesk; Werner Grote; Francisco Javier Novo; María José Calasanz; Reiner Siebert
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Primary marginal zone B-cell lymphoma of the lymph node resembling plasmacytoma arising from a plasma cell variant of Castleman's disease. A clinicopathological and immunohistochemical study of seven patients.

Authors:  Masaru Kojima; Shigeo Nakamura; Tadashi Motoori; Shunichi Shimano; Kayako Murayama; Yoshio Tamaki; Kazuhiko Shimizu; Tetsunari Oyama; Shiro Sugihara; Noriyuki Sakata; Nobuhide Masawa
Journal:  APMIS       Date:  2002-12       Impact factor: 3.205

Review 9.  Regulatory mechanisms that determine the development and function of plasma cells.

Authors:  Kathryn L Calame; Kuo-I Lin; Chainarong Tunyaplin
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers.

Authors:  Kai-Michael Toellner; William E Jenkinson; Dale R Taylor; Mahmood Khan; Daniel M-Y Sze; David M Sansom; Carola G Vinuesa; Ian C M MacLennan
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more
  8 in total

1.  Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype.

Authors:  Inmaculada Ribera-Cortada; Daniel Martinez; Virginia Amador; Cristina Royo; Alba Navarro; Silvia Beà; Eva Gine; Laurence de Leval; Sergio Serrano; Andrew Wotherspoon; Dolors Colomer; Antonio Martinez; Elías Campo
Journal:  Mod Pathol       Date:  2015-09-11       Impact factor: 7.842

Review 2.  The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing.

Authors:  Steven H Swerdlow; Isinsu Kuzu; Ahmet Dogan; Stephan Dirnhofer; John K C Chan; Birgitta Sander; German Ott; Luc Xerri; Leticia Quintanilla-Martinez; Elias Campo
Journal:  Virchows Arch       Date:  2015-10-10       Impact factor: 4.064

Review 3.  Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study.

Authors:  Sylvia Hoeller; Yi Zhou; Rashmi Kanagal-Shamanna; Zijun Y Xu-Monette; Daniela Hoehn; Michel Bihl; Steven H Swerdlow; Andreas Rosenwald; German Ott; Jonathan Said; Cherie H Dunphy; Carlos E Bueso-Ramos; Pei Lin; Michael Wang; Roberto N Miranda; Alexander Tzankov; L Jeffrey Medeiros; Ken H Young
Journal:  Hum Pathol       Date:  2012-08-31       Impact factor: 3.466

4.  New diagnosis of multiple myeloma in a patient with mantle cell lymphoma: Shared genetic factors or simple coincidence?

Authors:  Mutende J Sikuyayenga; Craig B Reeder; Joseph R Mikhael
Journal:  Leuk Res Rep       Date:  2012-11-10

5.  Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment.

Authors:  Man Fai Law; Hay Nun Chan; Charlotte Leung; Cheuk Kei Wong; Ho Kei Lai; Chung Yin Ha; Celia Ng; Yiu Ming Yeung; Sze Fai Yip
Journal:  Arch Med Sci       Date:  2017-04-20       Impact factor: 3.318

6.  The Diagnostic and Treatment Challenges of Concomitant Mantle Cell Lymphoma and IgM Myeloma.

Authors:  Dhairya Gor; Rohan Mehta; David Greenberg; Evgeniya Angelova
Journal:  Eur J Case Rep Intern Med       Date:  2022-07-07

Review 7.  The pathologic diagnosis of mantle cell lymphoma.

Authors:  Shaoying Li; Jie Xu; M James You
Journal:  Histol Histopathol       Date:  2021-06-11       Impact factor: 2.303

8.  Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma.

Authors:  Joanna C Dalland; James B Smadbeck; Neeraj Sharma; Reid G Meyer; Kathryn E Pearce; Patricia T Greipp; Jess F Peterson; Shaji Kumar; Rhett P Ketterling; Rebecca L King; Linda B Baughn
Journal:  Genes Chromosomes Cancer       Date:  2021-06-22       Impact factor: 5.006

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.